Freedom Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,867
| Closed | -$212K | – | 649 |
|
|
2020
Q3 | $212K | Sell |
10,867
-2,322
| -18% | -$45.3K | 0.02% | 494 |
|
|
2020
Q2 | $233K | Sell |
13,189
-3,933
| -23% | -$69.5K | 0.03% | 472 |
|
|
2020
Q1 | $141K | Buy |
17,122
+175
| +1% | +$1.44K | 0.01% | 636 |
|
|
2019
Q4 | $119K | Sell |
16,947
-1,564
| -8% | -$11K | 0.01% | 641 |
|
|
2019
Q3 | $222K | Sell |
18,511
-1,733
| -9% | -$20.8K | 0.02% | 606 |
|
|
2019
Q2 | $245K | Sell |
20,244
-355
| -2% | -$4.3K | 0.02% | 579 |
|
|
2019
Q1 | $259K | Sell |
20,599
-5,736
| -22% | -$72.1K | 0.02% | 560 |
|
|
2018
Q4 | $177K | Sell |
26,335
-10,964
| -29% | -$73.7K | 0.01% | 710 |
|
|
2018
Q3 | $355K | Buy |
37,299
+2,166
| +6% | +$20.6K | 0.02% | 655 |
|
|
2018
Q2 | $236K | Buy |
+35,133
| New | +$236K | 0.01% | 836 |
|